Investigation of the Methodology of Specific Airway Resistance Measurements in COPD

References

• Dean J, Panainte C, Khan N, Singh D. The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD. Respir Res. 2020;21:21. doi:10.1186/s12931-020-1278-5
   PubMed Web of Science ®Google Scholar
• Beardsmore CS. Chapter 5: plethysmography. Eur Respir Mon. 2010;47:66–86.
   Google Scholar
• Goldman MD, Smith HJ, Ulmer WT. Chapter 2: whole-body plethysmography. Eur Respir Mon. 2005;31:15–43.
   Google Scholar
• DuBois AB, Botelho SY, Comroe JH. A new method for measuring airway resistance in man using a body plethysmography: values in normal subjects and in patients with respiratory disease. J Clin Invest. 1956;35:327–335. doi:10.1172/JCI103282
   PubMed Web of Science ®Google Scholar
• Krell WS, Agrawal KP, Hyatt RE. Quiet-breathing vs. panting methods for determination of specific airway conductance. J Appl Physiol. 1984;57:1917–1922. doi:10.1152/jappl.1984.57.6.1917
   PubMed Web of Science ®Google Scholar
• Coutier L, Stouvenot M, Ioan I, et al. Specific airway resistance in preschool children: panting vs tidal breathing. Eur Respir J. 2014;44:1157.
   Web of Science ®Google Scholar
• Topalovic M, Exadaktylos V, Troosters T, Celis G, Aerts JM, Janssens W. Non-Linear parameters of specific resistance loops to characterise obstructive airways diseases. Respir Res. 2017;18(9). doi:10.1186/s12931-016-0484-7
   PubMedGoogle Scholar
• Graham BL, Steenbruggen I, Miller MR, et al. Standardization of Spirometry 2019 update: an official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. doi:10.1164/rccm.201908-1590ST
   PubMed Web of Science ®Google Scholar
• Kirkby J, Stanojevic S, Welsh L, et al. Reference equations for specific airway resistance in children: the Asthma UK initiative. Eur Respir J. 2010;36:622–629. doi:10.1183/09031936.00135909
   PubMed Web of Science ®Google Scholar
• Spann RW, Hyatt RE. Factors affecting upper airways resistance in conscious man. J Appl Physiol. 1971;31:708–712. doi:10.1152/jappl.1971.31.5.708
   PubMed Web of Science ®Google Scholar
• Hyatt RE, Wilcox RE. Extrathoracic airway resistance in man. J Appl Physiol. 1961;16:326–330. doi:10.1152/jappl.1961.16.2.326
   PubMed Web of Science ®Google Scholar
• Criee CP, Sorichter S, Smith HJ, et al. Body plethysmography - Its principles and clinical use. Respir Med. 2011;105:959–971. doi:10.1016/j.rmed.2011.02.006
   PubMed Web of Science ®Google Scholar
• Santus P, Radovanovic D, Henchi S, et al. Assessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patients. Respir Physiol Neurobiol. 2014;197:36–45. doi:10.1016/j.resp.2014.03.012
   PubMed Web of Science ®Google Scholar
• Higenbottam T, Payne J. Glottis narrowing in lung disease. Am Rev Respir Dis. 1982;125:746–750. doi:10.1164/arrd.1982.125.6.746
   PubMedGoogle Scholar
• Sekizawa K, Sasaki H, Takishima T. Laryngeal resistance immediately after panting in control and constricted airways. J Appl Physiol. 1985;58:1164–1169. doi:10.1152/jappl.1985.58.4.1164
   PubMed Web of Science ®Google Scholar
• van Noord J, Wellens W, Clarysse I, Cauberghs M, Van de Woestijne KP, Demedts M. Total respiratory resistance and reactance in patients with upper airway obstruction. Chest. 1987;92:475–480. doi:10.1378/chest.92.3.475
   PubMed Web of Science ®Google Scholar
• Biselli P, Grossman P, Kirkness J, et al. The effect of increased lung volume in chronic obstructive pulmonary disease on upper airway obstruction during sleep. J Appl Physiol. 2015;119:266–271. doi:10.1152/japplphysiol.00455.2014
   PubMed Web of Science ®Google Scholar
• Mahut B, Caumont-Prim A, Plantier L, et al. Relationships between respiratory and airway resistances and activity-related dyspnea in patients with chronic obstructive pulmonary disease. Int J COPD. 2012;7:165–171.
   Google Scholar
• Dean J, Kolsum U, Hitchen P, Gupta V, Singh D. Clinical characteristics of COPD patients with tidal expiratory flow limitation. Int J COPD. 2017;12:1503–1506. doi:10.2147/COPD.S137865
   Google Scholar
• Beech A, Jackson N, Dean J, Singh D. Expiratory flow limitation in a cohort of highly symptomatic COPD patients. ERJ Open Res. 2022;2022:8.
   Google Scholar
• Pedersen O, Butler J. Expiratory flow limitation. Compr Physiol. 2011;1:1861–1882.
   PubMed Web of Science ®Google Scholar
• Pecchiari M, Radovanovic D, Silianti C, et al. Tidal expiratory flow limitation induces expiratory looping of the alveolar pressure-flow relation in COPD patients. J Appl Physiol. 2020;129:75–83. doi:10.1152/japplphysiol.00664.2019
   PubMed Web of Science ®Google Scholar
• Ofir D, Laveneziana P, Webb K, Lam YM, O’Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:622–629. doi:10.1164/rccm.200707-1064OC
   PubMed Web of Science ®Google Scholar
• Briscoe WA, DuBois AB. The relationship between airway resistance, airway conductance and lung volume in subjects of different age and body size. J Clin Invest. 1958;37:1279–1285. doi:10.1172/JCI103715
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Hattori N, Haruta Y, et al. Effect of increasing respiratory rate on airway resistance and reactance in COPD patients. Respir. 2015;28:87–94.
   Google Scholar
• Ioan I, Demoulin-Alexikova S, Coutier L, et al. Specific airway resistance may be measured in preschool children during routine lung function. Eur Respir J. 2016;48:1804–1807. doi:10.1183/13993003.01302-2016
   PubMedGoogle Scholar
• Singh D, Hurst J, Martinez F, et al. Predictive modelling of COPD exacerbation rates using baseline risk factors. Ther Adv Respir Dis. 2022;16:1–15. doi:10.1177/17534666221107314
   Web of Science ®Google Scholar
• Soriano J, Lamprecht B, Ramirez A, et al. Mortality prediction in chronic pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of patient data. Lancet Respir Med. 2015;3:443–450. doi:10.1016/S2213-2600(15)00157-5
   PubMed Web of Science ®Google Scholar
• Hoesterey D, Das N, Janssens W, et al. Spirometric indices of early airflow impairment in individuals at risk of developing COPD: spirometry beyond FEV1/FVC. Respir Med. 2019;156:58–68. doi:10.1016/j.rmed.2019.08.004
   PubMed Web of Science ®Google Scholar
• Borrill Z, Houghton C, Tal-Singer R, et al. The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD. Br J Clin Pharmacol. 2007;65:244–252. doi:10.1111/j.1365-2125.2007.03013.x
   Web of Science ®Google Scholar
• Singh D, Brooks J, Hagan G, Cahn A, O’Connor BJ. Superiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. Thorax. 2008;63:592–598. doi:10.1136/thx.2007.087213
   PubMed Web of Science ®Google Scholar